Staphylococcus aureus endocarditis: The Grady Memorial Hospital experience

American Journal of the Medical Sciences

Volumn 331, Issue 2, 2006, Pages 84-87

  Sherwood, Matthew ^a   Smith, Dustin ^a   Crisel, Ryan ^a   Veledar, Emir ^a   Lerakis, Stamatios ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Emory Center for Outcomes Research ^*  (United States)

Author keywords

Endocarditis; Staphylococcus aureus

Indexed keywords

ADULT; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIUM CULTURE; DEMOGRAPHY; DISEASE COURSE; ECHOCARDIOGRAPHY; FEMALE; HOSPITAL INFECTION; HUMAN; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; PENICILLIN RESISTANCE; STAPHYLOCOCCUS AUREUS; COMMUNICABLE DISEASE; CROSS INFECTION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; STAPHYLOCOCCUS INFECTION; TREATMENT OUTCOME; UNITED STATES; UNIVERSITY HOSPITAL;

COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; ENDOCARDITIS, BACTERIAL; FEMALE; GEORGIA; HOSPITALS, UNIVERSITY; HUMANS; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

EID: 33644974048     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200602000-00014     Document Type: Article

References (17)

1. Roder BL, Wandall DA, Frimodt-Moller N, et al. Clinical features of Staphylococcus aureus endocarditis: a 10-year experience in Denmark. Arch Intern Med 1999;159:462-9.
2. Bouza E, Menasalvas A, Munoz P, et al . Infective endocarditis: a prospective study at the end of the twentieth century - new predisposing conditions, new etiologic agents, and still a high mortality. Medicine 2001;80:298-307.
3. Hoen B, Alla F, Selton-Suty C, et al. Association pour l'Etude et la Prevention de l'Endocarditeinfectieuse (AEPEI) Study Group. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 2002;288:75-81.
4. Cabell CH, Jollis JG, Peterson GE, et al. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med 2002;162:90-4.
5. Watanakunakorn C. Staphylococcus aureus endocarditis at a community teaching hospital, 1980 to 1991: an analysis of 106 cases. Arch Intern Med 1994;154:2330-5.
6. Fowler VG Jr, Sanders LL, Kong LK, et al. Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up. Clin Infect Dis 1999;28:106-14.
7. Chang FY, MacDonald BB, Peacock JE Jr, et al. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine 2003;82:322-32.
8. Edmond MB, Wallace SE, McClish DK, et al. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 1999;29:239-44.
9. Fowler VG Jr, Li J, Corey GR, et al. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J Am Coll Card 1997;30:1072-8.
10. Greaves K, Mou D, Patel A, et al. Clinical criteria and the appropriate use of transthoracic echocardiography for the exclusion of infective endocarditis. Heart 2003;89:273-5.
11. Habib G, Derumeaux G, Avierinos JF, et al. Value and limitations of the Duke criteria for the diagnosis of infective endocarditis. J Am Coll Cardiol 1999;33:2023-9.
12. Sekeres MA, Abrutyn E, Berlin JA, et al. An assessment of the usefulness of the Duke criteria for diagnosing active infective endocarditis. Clin Infect Dis 1997;24:1185-90.
13. Zetola N, Francis JS, Nuermberger EL, et al. Community-acquired methicillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 2005;5:275-86.
14. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 2003;36:131-9.
15. Fridkin SK, Hageman JC, Morrison M, et al. Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005;352:1436-44.
16. Harbarth S, Rutschmann O, Sudre P, et al. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch Intern Med 1998;158:182-9.
17. Soriano A, Martinez JA, Mensa J, et al. Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia. Clin Infect Dis 2000;30:368-73.